A presynaptic reduction of acetylcholine (ATCh) was found in patients with AD and amongst other Alzheimer’s treatments, inhibitors of acetylcholinesterase, that increase this neurotransmitter in the neocortical synaptic space, are the most common ones. Here, ACHE is linked to Alzheimer disease.